QQQ   426.72 (+0.21%)
AAPL   167.58 (-0.25%)
MSFT   409.94 (-0.46%)
META   508.59 (+2.92%)
GOOGL   155.85 (+0.24%)
AMZN   181.56 (+0.15%)
TSLA   149.94 (-3.54%)
NVDA   859.57 (+2.29%)
AMD   156.01 (+1.29%)
NIO   4.02 (+2.81%)
BABA   69.31 (+0.71%)
T   16.21 (+0.56%)
F   12.11 (+0.58%)
MU   112.67 (-3.15%)
GE   156.66 (+0.64%)
CGC   7.79 (+20.03%)
DIS   113.57 (+0.56%)
AMC   2.94 (-1.34%)
PFE   25.33 (-0.35%)
PYPL   62.62 (-1.01%)
XOM   118.84 (+0.18%)
QQQ   426.72 (+0.21%)
AAPL   167.58 (-0.25%)
MSFT   409.94 (-0.46%)
META   508.59 (+2.92%)
GOOGL   155.85 (+0.24%)
AMZN   181.56 (+0.15%)
TSLA   149.94 (-3.54%)
NVDA   859.57 (+2.29%)
AMD   156.01 (+1.29%)
NIO   4.02 (+2.81%)
BABA   69.31 (+0.71%)
T   16.21 (+0.56%)
F   12.11 (+0.58%)
MU   112.67 (-3.15%)
GE   156.66 (+0.64%)
CGC   7.79 (+20.03%)
DIS   113.57 (+0.56%)
AMC   2.94 (-1.34%)
PFE   25.33 (-0.35%)
PYPL   62.62 (-1.01%)
XOM   118.84 (+0.18%)
QQQ   426.72 (+0.21%)
AAPL   167.58 (-0.25%)
MSFT   409.94 (-0.46%)
META   508.59 (+2.92%)
GOOGL   155.85 (+0.24%)
AMZN   181.56 (+0.15%)
TSLA   149.94 (-3.54%)
NVDA   859.57 (+2.29%)
AMD   156.01 (+1.29%)
NIO   4.02 (+2.81%)
BABA   69.31 (+0.71%)
T   16.21 (+0.56%)
F   12.11 (+0.58%)
MU   112.67 (-3.15%)
GE   156.66 (+0.64%)
CGC   7.79 (+20.03%)
DIS   113.57 (+0.56%)
AMC   2.94 (-1.34%)
PFE   25.33 (-0.35%)
PYPL   62.62 (-1.01%)
XOM   118.84 (+0.18%)
QQQ   426.72 (+0.21%)
AAPL   167.58 (-0.25%)
MSFT   409.94 (-0.46%)
META   508.59 (+2.92%)
GOOGL   155.85 (+0.24%)
AMZN   181.56 (+0.15%)
TSLA   149.94 (-3.54%)
NVDA   859.57 (+2.29%)
AMD   156.01 (+1.29%)
NIO   4.02 (+2.81%)
BABA   69.31 (+0.71%)
T   16.21 (+0.56%)
F   12.11 (+0.58%)
MU   112.67 (-3.15%)
GE   156.66 (+0.64%)
CGC   7.79 (+20.03%)
DIS   113.57 (+0.56%)
AMC   2.94 (-1.34%)
PFE   25.33 (-0.35%)
PYPL   62.62 (-1.01%)
XOM   118.84 (+0.18%)
Free Trial

GeneDx (WGS) Stock Forecast & Price Target

→ A.I. Pioneer Issues Urgent Warning to Americans (From TradeSmith) (Ad)
Free WGS Stock Alerts
$9.40
+0.20 (+2.17%)
(As of 12:27 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

GeneDx Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 1 Analyst Ratings

Analysts' Consensus Price Target

$11.00
17.02% Upside
High Forecast$11.00
Average Forecast$11.00
Low Forecast$11.00
TypeCurrent Forecast
4/19/23 to 4/18/24		1 Month Ago
3/20/23 to 3/19/24		3 Months Ago
1/19/23 to 1/19/24		1 Year Ago
4/19/22 to 4/19/23
Consensus Rating
Hold
N/AN/A
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
 N/A N/A
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
 N/A N/A
3 Buy rating(s)
Hold
1 Hold rating(s)
 N/A N/A
2 Hold rating(s)
Sell
0 Sell rating(s)
 N/A N/A
0 Sell rating(s)
Consensus Price Target$11.00N/AN/A$88.00
Predicted Upside17.02% UpsideN/AN/A125.07% Upside
Get GeneDx Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter.

WGS Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

WGS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

GeneDx Stock vs. The Competition

TypeGeneDxMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.68
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside19.57% Upside934.34% Upside12.27% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/15/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetNeutral ➝ Neutral$11.00+18.92%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 12:43 PM ET.

WGS Price Target - Frequently Asked Questions

What is GeneDx's consensus rating and price target?

According to the issued ratings of 1 analysts in the last year, the consensus rating for GeneDx stock is Hold based on the current 1 hold rating for WGS. The average twelve-month price prediction for GeneDx is $11.00 with a high price target of $11.00 and a low price target of $11.00. Learn more on WGS's analyst rating history.

Do Wall Street analysts like GeneDx more than its competitors?

Analysts like GeneDx less than other Medical companies. The consensus rating for GeneDx is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how WGS compares to other companies.

Does GeneDx's stock price have much upside?

According to analysts, GeneDx's stock has a predicted upside of 18.92% based on their 12-month stock forecasts.

What analysts cover GeneDx?

GeneDx has been rated by The Goldman Sachs Group in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:WGS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
He Is Giving Away Bitcoin
Crypto Swap Profits
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Paradigm Press
The Next Nvidia?
InvestorPlace
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
Urgent alert: open this for a huge profit potential
Timothy Sykes